ZA202211266B - Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof - Google Patents

Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof

Info

Publication number
ZA202211266B
ZA202211266B ZA2022/11266A ZA202211266A ZA202211266B ZA 202211266 B ZA202211266 B ZA 202211266B ZA 2022/11266 A ZA2022/11266 A ZA 2022/11266A ZA 202211266 A ZA202211266 A ZA 202211266A ZA 202211266 B ZA202211266 B ZA 202211266B
Authority
ZA
South Africa
Prior art keywords
midbrain
neurons
methods
generating
dopamine
Prior art date
Application number
ZA2022/11266A
Other languages
English (en)
Inventor
Lorenz Studer
Tae-Wan Kim
So-Yeon Koo
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Publication of ZA202211266B publication Critical patent/ZA202211266B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2022/11266A 2020-04-02 2022-10-13 Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof ZA202211266B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063004138P 2020-04-02 2020-04-02
PCT/US2021/025596 WO2021203009A1 (en) 2020-04-02 2021-04-02 Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof

Publications (1)

Publication Number Publication Date
ZA202211266B true ZA202211266B (en) 2023-05-31

Family

ID=77929755

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/11266A ZA202211266B (en) 2020-04-02 2022-10-13 Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof

Country Status (12)

Country Link
US (1) US20230143486A1 (https=)
EP (1) EP4127137A4 (https=)
JP (2) JP2023520466A (https=)
KR (1) KR20220164012A (https=)
CN (1) CN115768875A (https=)
AU (1) AU2021248640A1 (https=)
BR (1) BR112022019881A2 (https=)
CA (1) CA3177525A1 (https=)
IL (1) IL296919A (https=)
MX (1) MX2022012366A (https=)
WO (1) WO2021203009A1 (https=)
ZA (1) ZA202211266B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023220639A2 (en) * 2022-05-10 2023-11-16 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for improved memory in the aging
US12565639B2 (en) 2023-06-13 2026-03-03 Aspen Neuroscience, Inc. Methods for differentiating dopaminergic neurons from stem cells
WO2025166063A1 (en) 2024-01-31 2025-08-07 Bluerock Therapeutics Lp Igfbp2 in cell culture
WO2025252180A1 (zh) * 2024-06-05 2025-12-11 中国科学院脑科学与智能技术卓越创新中心 中脑多巴胺能祖细胞群的体外制备方法
WO2026006245A1 (en) * 2024-06-25 2026-01-02 Bluerock Therapeutics Lp Three-dimensional culturing of pluripotent stem cells for improved differentiability

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3693455A1 (en) * 2011-11-04 2020-08-12 Memorial Sloan-Kettering Cancer Center Midbrain dopamine (da) neurons for engraftment
EP2614829A1 (en) * 2012-01-11 2013-07-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons
WO2014161075A1 (en) * 2013-04-05 2014-10-09 University Health Network Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue
EP3498824A1 (en) * 2013-04-26 2019-06-19 Memorial Sloan-Kettering Cancer Center Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
WO2017160234A1 (en) * 2016-03-14 2017-09-21 Agency For Science, Technology And Research Generation of midbrain-specific organoids from human pluripotent stem cells

Also Published As

Publication number Publication date
KR20220164012A (ko) 2022-12-12
WO2021203009A1 (en) 2021-10-07
US20230143486A1 (en) 2023-05-11
CN115768875A (zh) 2023-03-07
JP2025184905A (ja) 2025-12-18
IL296919A (en) 2022-12-01
CA3177525A1 (en) 2021-10-07
EP4127137A4 (en) 2024-05-22
JP2023520466A (ja) 2023-05-17
AU2021248640A1 (en) 2022-10-27
MX2022012366A (es) 2022-12-15
EP4127137A1 (en) 2023-02-08
BR112022019881A2 (pt) 2022-11-22

Similar Documents

Publication Publication Date Title
ZA202211266B (en) Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof
ZA202202994B (en) Methods of generating and isolating midbrain dopamine neurons
IL312607B2 (en) Interleukin-21 Mutants and Treatment Methods
HUE061834T2 (hu) MAT2A aza-heterobiciklusos inhibitorai és alkalmazási eljárások rák kezelésére
IL281445A (en) Therapeutic nanoparticles and methods for their use
ZA202007839B (en) Polymerases, compositions, and methods of use
AU2018274043A1 (en) N-(azaaryl)cyclolactam-1-carboxamide derivative, preparation method therefor, and use thereof
IL253301A0 (en) Internal organ treatment and fertility
EP3684756A4 (en) SYNTHESIS OF N-ACETYLCYSTEIN AMIDE AND ITS DERIVATIVES
IL269901B (en) Pharmaceutical compounds and methods of treating cardiovascular diseases
WO2018094106A3 (en) ALLOSTERIC ANTAGONISTS OF GPRC6a AND THEIR USE IN MITIGATING PROTEINOPATHIES
EP3720376A4 (en) ACTIVE COMPRESSION APPARATUS, ASSEMBLY METHODS AND METHODS OF USE
IL304504A (en) Modified Mir-135, its coupling and uses
IL279377A (en) Methods for assessment and early detection of stress, selection and monitoring of treatment and new use of drugs
GB202010768D0 (en) Cable-tidy apparatus, and method of use thereof
IL307752A (en) Intracardiac device and methods of use
IL304719A (en) Methods for preparing scrapomes and their uses
GB201910042D0 (en) Security devices and methods of manufacture
EP3730484C0 (en) INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR, PREPARATION METHOD AND APPLICATION THEREOF
SG11202104018TA (en) An implantable construct, methods of manufacturing, and uses thereof
EP3706781A4 (en) METHODS OF TREATMENT AND PROTECTION AGAINST HEART DISEASE, CARDIOVASCULAR DISEASE AND ASSOCIATED CONDITIONS AND SYMPTOMS
HK40075940B (en) Methods of generating and isolating midbrain dopamine neurons
EP3501493A4 (en) ANTI-WRINKLE COSMETIC COMPOSITION, USE OF THE COMPOSITION, ANTI-WRINKLE TREATMENT METHOD AND APPLICATION DEVICE
SG11202101180YA (en) Methods of generating and testing aqueous gas streams
GB202106040D0 (en) Methods and uses